SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-219696
Filing Date
2021-07-20
Accepted
2021-07-20 16:36:54
Documents
3
Period of Report
2021-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d172723d8k.htm 8-K 23040
2 EX-3.1 d172723dex31.htm EX-3.1 39419
3 EX-3.2 d172723dex32.htm EX-3.2 154089
  Complete submission text file 0001193125-21-219696.txt   217843
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 211101548
SIC: 2836 Biological Products, (No Diagnostic Substances)